Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


A novel ULK1 agonist with cytoprotective autophagy modulation in Parkinson's disease

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-A-031-Tuesday
  • By: OUYANG, Liang (Chengdu, China)
  • Co-author(s): Lan Zhang: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy, Sichuan university, Chengdu, China
    Liang Ouyang: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, China
  • Abstract:

    Backgrounds

    Autophagy is an evolutionarily conserved, multi-step lysosomal degradation process, in which a cell degrades long-lived proteins and damaged organelles. Defects in autophagy have implications for therapy of Parkinson's disease (PD), and thus activation of autophagy would be a promising strategy. UNC-51-like kinase 1(ULK1), the yeast Atg1..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses